Molekule Group (FRA:9O6) ROCE % : -86.86% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Molekule Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Molekule Group's annualized ROCE % for the quarter that ended in Jun. 2023 was -86.86%.

Molekule Group ROCE % Historical Data

The historical data trend for Molekule Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molekule Group ROCE % Chart

Molekule Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

ROCE %

-292.04

-67.13

-76.15

Molekule Group Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
ROCE %	Get a 7-Day Free Trial									-83.82	-71.92	-73.81	-52.26	-86.86

Molekule Group ROCE % Calculation

Molekule Group's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-16.325	/	( ( (20.995 - 1.337)	+	(27.526 - 4.307) )	/ 2 )
	=	-16.325	/	( (19.658	+	23.219)	/ 2 )
	=	-16.325	/	21.4385
	=	-76.15 %

Molekule Group's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Mar. 2023 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Mar. 2023 )		(Q: Jun. 2023 )
	=	-87.2	/	( ( (120.004 - 19.041)	+	(115.781 - 15.964) )	/ 2 )
	=	-87.2	/	( ( 100.963	+	99.817 )	/ 2 )
	=	-87.2	/	100.39
	=	-86.86 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

Molekule Group (FRA:9O6) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Molekule Group ROCE % Related Terms

Thank you for viewing the detailed overview of Molekule Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Molekule Group (FRA:9O6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (FRA:9O6) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

MKULQ:USA

Address

10455 Riverside Drive, Palm Beach Gardens, FL, USA, 33410

Website

https://www.molekule.com

Molekule Group Inc is an interior space air purification technology company with an immediate objective of initiating full-scale commercialization of its high-performance interior air sterilization and disinfection products for the eradication of coronavirus and other harmful airborne pathogens. The Company was established to develop technology-driven, medical-grade air purification solutions for hospitals and other healthcare settings. Its air hygiene product, Purgo, is an FD medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology that can be applied in any indoor space including in hospitals, offices, and even in elevators.

Molekule Group (FRA:9O6) Headlines

No Headlines